The original agreements developed by the Brunswick Group have been revised and updated through an initiative sponsored by the Russell Group. To find the full list of organisations that have signed up to use these templates, please click here. They are based upon both the earlier Brunswick agreements and a suite of agreements which had been generated and agreed for use by all Scottish universities and have been subject to consultation with both Russell Group and Brunswick Group Universities. They have been updated to accommodate changes that have come to the fore since their inception and to reflect the English jurisdiction, where applicable.
The current revised agreements are:
Research Collaboration agreements
The Academic Research Collaboration Agreements (short and long) have been designed to be suitable for the majority of cases where two or more universities receive a joint grant from a research council or charity. Occasionally a different arrangement will be required, but in the absence of special circumstances it is expected that one of the Brunswick Agreements will be used.
Short Form Joint Award Letter
This simple letter is designed to be issued by a lead institution to provide funding and to bind a collaborating co-applicant institution into the terms of a research council’s or research charity’s terms and conditions. It is intended that the Short Form Joint Award Letter should govern collaborations which are funded by research councils and charities where:
the award is made for a research project (not a Centre) under standard terms;
the collaborators are academic or non-profit making institutions;
the collaborating institutions are named in the application as undertaking a specific and significant proportion of the project; and
the terms of the award do not restrict the universities’ ownership or publication of
Grant Joint Award Agreement
The Grant Joint Award Agreement is designed to be used in funded collaborations where some more complex issues may need to be catered for, such as establishing project management groups, the introduction and use of valuable intellectual property and particular confidentiality or publication concerns. This does not deal with all eventualities and may need to be amended in response to specific circumstances.
Material Transfer & Human Tissue Agreements
The Material Transfer Agreement is designed to balance the needs of both the donor and recipient organisations. It is reasonable to expect that for routine transfers of materials, universities should be prepared to sign up to identical terms for both incoming and outgoing transfers. It is therefore expected that in the vast majority of cases, parties will be able to sign up to the terms without modification, regardless of whether they are the donor or recipient.
The approach is deliberately minimal, and is not intended to cater for all situations. For instance, it is not suitable for use where human tissue is being transferred or situations where there is known to be an IP position that needs careful treatment. The inclusion of onerous IP terms “just in case IP is an issue” has been avoided.
This agreement is not designed for use between universities and commercial organisations. A template Human Tissue MTA was produced under the original Brunswick Group initiative.
The Brunswick Studentship agreement is for use between a university and a company for the support of a postgraduate research student.
We have created this toolkit for universities and companies that wish to undertake collaborative research projects with each other. The toolkit consists of:
- Set of 5 model research collaboration (one to one) agreements
- 4 Consortium (multi-party) agreements
- Decision guide
- Guidance documents
The Lambert Working Group on Intellectual Property (IP) prepared the toolkit. The objectives of the toolkit are to:
- Facilitate negotiations between potential collaborators
- Reduce the time and effort required to secure agreement
- Provide examples of best practice
Nationally approved standard Agreements help speed up the contracting process for industry-sponsored trials carried out in the NHS by removing the need for site-by-site reviews and local legal agreements to be drawn up. This enables trials to start earlier, improving the speed of industry-sponsored clinical trials and giving NHS patients faster access to innovative treatments.
The suite of model Agreements are supported by Guidance which sets out the aims and provides details on how the Agreement should be used in the development of contracts for clinical research sponsored by pharmaceutical, biopharmaceutical or medical technology companies.
Please find below some articles, websites and information that may be of interest: